Richard F Fitzgerald
CIK 1459933 · Chief Financial Officer · last filed 2022-03-23
Richard F Fitzgerald is a Chief Financial Officer who has filed 12 SEC Form 4 insider transactions across 5 companies since 2016. The most recent filing, for XXII, was dated Mar 23, 2022. 4 SEC filings were submitted jointly with PAVmed Inc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
PAVM.U price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
ONE BELLA DRIVE
WESTMINSTER, MA 01473
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XXII | Chief Financial Officer | 0 | $1.59 | $0 | $0 | 1 | 2022-03-23 |
| IMNM | Chief Financial Officer | — | $19.66 | — | $0 | 1 | 2020-10-05 |
| Carisma Therapeutics Inc. (SESN) Delisted | Chief Financial Officer | — | $12.58 | — | $0 | 1 | 2019-02-25 |
| Carisma Therapeutics Inc. (EBIO) Delisted | Chief Financial Officer | — | — | — | $0 | 2 | 2018-04-11 |
| PAVmed Inc. (PAVM.U) Delisted | CFO and Secretary | 200 | — | — | $0 | 3 | 2016-06-03 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-03-23 | XXII | Grant (A) | +124,722 | $0 | EDGAR |
| 2020-10-05 | IMNM | Grant (A) | — | $0 | EDGAR |
| 2019-02-25 | Carisma Therapeutics Inc. (SESN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-04-11 | Carisma Therapeutics Inc. (EBIO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-01-25 | Carisma Therapeutics Inc. (EBIO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-06-03 | PAVmed Inc. (PAVM.U) Delisted | Mixed | +200 | $0 | EDGAR |
| 2016-05-27 | PAVmed Inc. (PAVM.U) Delisted | Mixed | +100 | $0 | EDGAR |
| 2016-05-02 | PAVmed Inc. (PAVM.U) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-09-14 | — | Tax (F) | +67,500 | $5.4K | |
| 2013-06-17 | — | Grant (A) | — | $0 |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.